Don't let Ab­b­Vie fool FTC with an easy di­vesti­ture, plead crit­ics in lat­est at­tack on $63B Al­ler­gan buy­out

If the FTC must let Ab­b­Vie and Al­ler­gan go ahead with their merg­er, at least make them di­vest their lat­est block­buster on the mar­ket, a …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.